Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination

• Weijun Zhao,
• Huajun Zhao,
• Baoying Huang,
• Tongyi Zhao,
• Limei Wang,
• Jian Zhang,
• Yong Yang,
• Xinying Tang,
• Wenjie Tan,
• Ang Lin

Affiliations

Weijun Zhao

Vaccine Center, School of Basic Medicine and Clinical Pharmacy; Center for New Drug Safety Evaluation and Research, China Pharmaceutical University

Huajun Zhao

Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences; Advanced Medical Research Institute, Shandong University

Baoying Huang

NHC Ley Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention

Tongyi Zhao

Vaccine Center, School of Basic Medicine and Clinical Pharmacy; Center for New Drug Safety Evaluation and Research, China Pharmaceutical University

Limei Wang

Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences; Advanced Medical Research Institute, Shandong University

Jian Zhang

Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences; Advanced Medical Research Institute, Shandong University

Yong Yang

Vaccine Center, School of Basic Medicine and Clinical Pharmacy; Center for New Drug Safety Evaluation and Research, China Pharmaceutical University

Xinying Tang

Vaccine Center, School of Basic Medicine and Clinical Pharmacy; Center for New Drug Safety Evaluation and Research, China Pharmaceutical University

Wenjie Tan

NHC Ley Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention

Ang Lin

Vaccine Center, School of Basic Medicine and Clinical Pharmacy; Center for New Drug Safety Evaluation and Research, China Pharmaceutical University